Monitoring antiviral active metabolite (N-hydroxycytidine) levels in plasma in presence of carboxylesterase-2 inhibitor verapamil using copper tetracyanoquinodimethane enhanced sensor-Reference-Cited by-同舟云学术

Monitoring antiviral active metabolite (N-hydroxycytidine) levels in plasma in presence of carboxylesterase-2 inhibitor verapamil using copper tetracyanoquinodimethane enhanced sensor

Published:2023-11 Issue: Volume:194 Page:109330
ISSN:0026-265X
Container-title:Microchemical Journal
language:en
Short-container-title:Microchemical Journal

Author:

Alanazi Ahmed Z.,Alhazzani Khalid,Mostafa Aya M.,Barker James,Mohamed Sabrein H.,El-Wekil Mohamed M.,Ali Al-Montaser Bellah H.

Funder

King Saud University

Publisher

Elsevier BV

Subject

Spectroscopy,Analytical Chemistry

Reference49 articles.

1. The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infection;Painter;Antiviral Res.,2019

2. T.P. Sheahan, A.C. Sims, S. Zhou, R.L. Graham, C.S. Hill, S.R. Leist, A. Schäfer, K.H. Dinnon III, S.A. Montgomery, M.L. Agostini, An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 and multiple endemic, epidemic and bat coronavirus, Biorxiv, (2020) 2020.2003. 2019.997890.

3. Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia;Toots;Sci. Transl. Med.,2019

4. The COVID-19 oral drug molnupiravir is a CES2 substrate: potential drug-drug interactions and impact of CES2 genetic polymorphism in vitro;Shen;Drug Metab. Dispos.,2022

5. A validated LC-MS/MS method for determination of antiviral prodrug molnupiravir in human plasma and its application for a pharmacokinetic modeling study in healthy Egyptian volunteers;Gouda;J. Chromatogr. B, Anal. Technol. Biomed. Life Sci.,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A newly developed and validated environmentally friendly RP-HPLC stability indicating method for the COVID-19 antiviral Molnupiravir: Application to degradation kinetics structure suggestion using LC-MS and the effect on viable cells of the major degradation products;Microchemical Journal;2024-04